CD30 Antibody – Mouse Monoclonal

MBS6267856 is an antibody targeting CD30. Also known as CD30 (CD30L Receptor, D1S166E, Ki1 Antigen, Lymphocyte Activation Antigen CD30, Tumor Necrosis Factor Receptor Superfamily Member 8 Precursor, Hodgkin & Reed-Sternberg Cell Marker, TNFRSF8) (BSA & Azide Free) (MaxLight 650). Reactive in Human. Host: Mouse.

1. Schwarting R, et. al. Blood, 1989, 74(5):1678- 89. 2. Battelli MG, et al. Virchows Archiv, 1996 Feb, 427(5):529-35. 2. Bolognesi A, et ak, International Journal of Cancer, 1996 Nov 4, 68(3):349-55. 3. Hittmair A, et al. Human Pathology, 1996 Nov, 27(11):1166-71. 4. Terenzi A, et al. British Journal of Haematology, 1996 Mar, 92(4):872-9. 5. Zakowski MF, et al. Diagnostic Cytopathology, 1996 Mar, 14(2):155-61. 6. Bolognesi A, et al. Cancer Immunology, Immunotherapy, 1995 Feb, 40(2):109-14. 7. Fraga M, et al. American Journal of Clinical Pathology, 1995 Jan, 103(1):82-9. 8. Horn-Lohrens O, et al. International Journal of Cancer, 1995 Feb 8, 60(4):539-44. 9. Latza U, et al. American Journal of Pathology, 1995 Feb, 146(2):463-71. 10. Pasqualucci L, et al. Blood, 1995 Apr 15, 85(8):2139-46. 11. Sass U, et al. Dermatology, 1995, 190(4):327-9. 12. Tian ZG, et al. Cancer Research, 1995 Nov 15, 55(22):5335-41. 13. Zarate-Osorno A, et al. Cancer, 1995 Mar 15, 75(6):1360-6. 14. Battelli MG, et al. Hepatology, 1994 Oct, 20(4 Pt 1):940-7. 15. el-Azhary RA, et al. Journal of the American Academy of Dermatology, 1994 Feb, 30(2 Pt 1):210-8. 16. Ferreiro JA, et al. Human Pathology, 1994 May, 25(5):522-4. 17. Ito K, et al. American Journal of Pathology, 1994 Aug, 145(2):276-80. 18. Oka K, et al. Dermatology, 1994, 188(1):52-6. 19. Schwend M, et al. European Respiratory Journal, 1994 Mar, 7(3):612-6. 20. Cambiaggi A, et al. British Journal of Haematology, 1993 Oct, 85(2):270-6. 21. Charalambous C, et al. Journal of Clinical Pathology, 1993 Dec, 46(12):1085-8. 22. Enblad G, et al. Histopathology, 1993 Jun, 22(6):535-41. 23. Gordon BG, et al. Cancer, 1993 Jan 1, 71(1):257-63. 24. Krishnan J, et al. Journal of Cutaneous Pathology, 1993 Jun, 20(3):193-202. 25. Parente A, et al. Biochim Biophys Acta, 1993 Oct 19, 1216(1):43-9. 26. Tallini G, et al. Journal of Clinical Gastroenterology, 1993 Jul, 17(1):57-66. 27. Vanbockrijck M, et al. Cancer, 1993 Sep 1, 72(5):1784-9. 28. Durkop H, et al. Cell, 1992 Feb 7, 68(3):421-7. 29. Falini B, et al. Lancet, 1992 May 16, 339(8803):1195- 6. 30. Falini B, et al. British Journal of Haematology, 1992 Sep, 82(1):38-45. 31. Kanzaki T, et al. Cancer, 1992 Feb 15, 69(4):1034-41. 32. Miyazono M, et al. Acta Neuropathologica, 1992, 84(5):577- 80. 33. Perkins PL, et al. Archives of Pathology and Laboratory Medicine, 1992 Nov, 116(11):1192-6. 34. Sarker AB, et al. American Journal of Pathology, 1992 Jul, 141(1):19-23.

Small volumes of anti-CD30 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.